Pravastatin versus simvastatin

Common Questions and Answers about Pravastatin versus simvastatin


Avatar m tn "Feb. 28, 2012 -- Memory loss, confusion, high blood sugar, and type 2 diabetes are possible side effects of the popular cholesterol-lowering drugs known as statins, the FDA warns. Brand name and generic versions of statin drugs must carry these warnings on their labels, the FDA today announced.
Avatar f tn The study found that the patients on simvastatin achieved the target LDL level of less than 130, more than those on pravastatin (65 percent on simvastatin versus 35 percent on pravastatin). The most common side effects of the statins in general are nausea, gas, and upset stomach. Less common are headache, dizziness, rash, sleep disturbances, muscle pain, cramps, or weakness.
Avatar m tn • atorvastatin (Lipitor) • fluvastatin (Lescol) • lovastatin (Mevacor) • pravastatin (Pravachol) • simvastatin (Zocor) With increasing rates of obesity and associated metabolic conditions – both in HCV positive individuals and in the population as a whole – the statins have become one of the most widely prescribed classes of drugs Statins and HCV In the July 2006 issue of Hepatology, M.
Avatar f tn I don't have fatty liver though...thanks good you dont have fatty liver but add simvastatin to your treatment, it has 505 reducton on hcc risk, the highest hcc risk reduction Yes will try to find ways to have hbsAg quantity tested. When you said "etv+intf combo", do you refer to sequential combo (etv first, then intf add-on at later time)? you can try both sequential or combo directly, the point is getting rid of hbsag or lower it.
Avatar m tn The lipid modification effects appeared to be similar to pravastatin, simvastatin, lovastatin, atorvastatin, or fluvastatin. Compared with non-statin lipid lowering agents, RYR preparations appeared superior to nicotinate and fish oils, but equal to or less effective than fenofibrate and gemfibrozil. No significant difference in lipid profile was found between Xuezhikang and Zhibituo.
976897 tn?1379171202 The aim of this review of the landmark HMG-CoA reductase inhibitors (statins) studies is to enable the clinician to draw practical lessons from these trials. The Scandinavian Simvastatin Survival Study (4S) established the importance of treating the hypercholesterolemic patient with established cardiovascular heart disease.